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Abstract (215 words) 
Measurement of parasite proliferation in cultured red blood cells underpins many facets of malaria 
research, from drug sensitivity assays to assessing the impact of experimentally altered genes on 
parasite growth, virulence, and fitness.  Pioneering efforts to grow Plasmodium falciparum in 
cultured red blood cells revolutionized malaria research and spurred the development of semi-high 
throughput growth assays using radio-labeled hypoxanthine, an essential nucleic acid precursor, as a 
reporter of whole-cycle proliferation (Trager and Jensen, 1976; Desjardins et al., 1979). Use of 
hypoxanthine (Hx) and other surrogate readouts of whole-cycle proliferation remains the dominant 
choice in malaria research.  While amenable to high-throughput inference of bulk proliferation 
rates, these assays are blind to the underlying developmental and cellular steps of growth in human 
red blood cells.  Modern whole-genome methods promise to reveal much about basic parasite 
biology, but progress is hindered by limitations of our ability to precisely quantify the specific 
development and growth events within the erythrocytic cycle.  Here we build on standard visual and 
Hx-incorporation measures of growth by quantifying sub-phenotypes of a rapid proliferator, the 
multi-drug resistant clone Dd2, from a standard wild type clone, HB3.  These data illustrate 
differences in cycle duration, merozoite production, and invasion rate and efficiency that underpin 
Dd2’s average 2-fold proliferation advantage over HB3 per erythrocytic cycle.  The ability to 
measure refined growth phenotypes can inform the development of high-throughput methods to 
isolate molecular and developmental determinants of differential parasite growth rates. 
 
Key words: malaria, phenotypes, growth rate, cell cycle, schizogony, invasion, virulence, fitness 
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1. Introduction 
Once the focus of a global eradication campaign, malaria is again entrenched, infecting over 500 
million people each year and killing as many as 2 million (Snow et al., 2005).  Proliferation of 
Plasmodium falciparum in red blood cells (RBC) is the basis for tertian fever cycles characteristic 
of this most devastating form of malaria.  The classically reported 48h periodicity of fever is due to 
synchronous parasite development in RBC, corresponding lysis, and massive liberation of newly 
produced merozoites and toxins.  Higher multiplication rates lead to higher parasite biomass which 
is known to correlate with disease severity in patients from SE Asia (Chotivanich et al., 2000; 
Timms et al., 2001; Dondorp et al., 2005).  In addition to the epidemiological significance of 
quantifying growth and its relationship to virulence, the role of parasite genes, pathways and 
regulatory networks in modulating strain-specific growth and proliferation differences remains 
largely unexplored.  Knowledge of these mechanisms will help refine attacks on the parasite 
through rational drug design, small molecule library screens (Baniecki et al., 2007), and choices of 
drug combinations.  In general, P. falciparum parasites are described as progressing from rings (0-
24hrs) to trophozoites (24-36) to schizonts (36-48), culminating in the formation of new individual 
merozoites packaged in mature schizonts that initiate subsequent invasion of uninfected cells.  In 
this asexual cycle a single merozoite leads to the development of 10 or more new merozoites per 
cell cycle (Roberts and Janovy, 2000).  Each stage has been well characterized for gene expression, 
biochemistry, and morphology (Ben Mamoun et al., 2001), but strikingly little is understood about 
the natural variation in, and regulation of these processes.   
 
Development of in vitro culturing of P. falciparum provided powerful experimental access to this 
parasite, and was followed closely by development of methods to infer parasite viability and 
proliferation (Trager and Jensen, 1976; Richards and Maples, 1979; Trager and Jensen, 1997).  
Visualization by Giemsa-stained blood smears remains the definitive, but cumbersome, method for 
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discerning parasitemia and viability.  Desjardins and co-workers developed a semi high-throughput, 
quantitative assay using incorporation of an essential radio-labeled nucleic acid precursor, 
hypoxanthine (Hx) (Desjardins et al., 1979). Subsequent optimizations made this assay the gold 
standard, effectively mirroring visually determined parasitemias (Chulay et al., 1983; Yayon et al., 
1983).   
 
Several other methods have been described for monitoring parasite growth that attempt to mirror the 
well-established Hx-based assays. While having the advantage of not requiring radioactivity, none 
of these assays has been adapted to measure the steps of the growth process. Lactate dehydrogenase 
(pLDH) provides an accurate count of parasites when compared with parasitemia determined by 
smears (Makler and Hinrichs, 1993).  Though useful in ascertaining parasitemias and drug 
sensitivities (Makler and Hinrichs, 1993; Makler et al., 1993), the reagents are light sensitive, and 
some precision is lost in determination of dose-concentration effects, especially at low parasitemias. 
More recently, fluorescent labels such as SYBR Green I, a DNA intercalating dye, have been used 
to measure parasite growth and show great promise for high-throughput applications (Johnson et al., 
2007).  The SYBR green method measures parasite density almost instantaneously (Bennett et al., 
2004) and gives similar inhibition curves and EC50 values for drug tests when compared to 
standard radioisotope methods (Smilkstein et al., 2004).  As for the standard Hx assays, these 
methods are currently used to indicate expansion of parasite numbers over complete cycles and 
consequently serve as  ‘black box' readouts that synonomize the events of the growth processes, i.e., 
the sub-phenotypes that underpin bulk proliferation rates.   
 
Here, we quantitatively dissect the steps of growth in red blood cells by quantifying a series of 
traits, ranging from classical proliferation using blood smears and Hx incorporation to several 
nested steps of growth: cell cycle progression and duration, merozoite production, and re-invasion 
  5 
efficiency.  These two parasite clones, Dd2, a fast growing multi-drug resistant (MDR) parasite 
derived from an Indochina isolate, and HB3, a generally drug sensitive parasite from Honduras.  
were previously crossed to generate a segregating population of progeny (Wellems et al., 1990),. 
Traits characterized within this cross provide a baseline for efforts to genetically map determinants 
of differential growth rates.  Genetically defined growth loci will provide an entry point into 
elucidating genes and mechanisms regulating parasite progression aiding in the development of 
drugs.  Characterization of these traits provides a higher resolution of cellular events contributing to 
rapid proliferation.  Such resolution will be imperative to fully access the power of new whole-
genome technologies, chemical genetic screens, and broad-scale gene knockouts and mutagenesis.   
 
2. Materials and Methods 
Culture-based assays in P. falciparum are significantly influenced by subtle variations in 
hematocrit, parasite inoculums and life-cycle stage diversity (Chulay et al., 1983; Yayon et al., 
1983).  Consequently, for these studies culturing protocols, management of parasite stocks, and 
experimental design were rigorously standardized, including both technical and biological 
replications.  Each experiment was conducted with fresh cultures of HB3 and Dd2 parasites derived 
from genotyped stock material as a common starting point, eliminating the concern of variation 
introduced by long-term culturing.   
 
2.1. Parasite culture 
Parasites were grown in fresh complete media (CM) [370µM hypoxanthine (Sigma), and 25mM 
HEPES (Sigma); 0.5% Albumax II (Gibco), 10µg/mL gentamicin (Gibco), and 0.225% sodium 
bicarbonate (Biosource) in RPMI-1640 medium (Gibco)], O+ RBC (5.0% hematocrit).  Albumax, 
rather than serum, was used to avoid effect of host variation on parasite growth.  All reagents were 
prepared from the same lots throughout these experiments. Cultures were maintained at constant 
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pH, 7.2-7.4, and temperature, 37ºC.  Culturing involved daily media changes maintaining 1-5% 
parasitemia to minimize stress and gassing to maintain an atmosphere of 5% CO2/ 5% O2/ 90% N2.  
This base protocol was slightly modified for specific phenotype assays as described. Temperature 
effects were not specifically controlled for, however every culture was handled identically 
throughout the experiments and flasks were at room temperature for only 5 minutes during media 
changes and gassing.   
 
2.2. Proliferation: Visual growth determination  
Five mL cultures containing new rings were synchronized with 5% aqueous D-sorbitol (Fluka 
BioChemika) in RPMI, and resuspended in 5mL of CM.  The next day, parasitemia was reduced by 
1/5 with the addition of uninfected RBC and fresh CM.  After an additional cycle, parasites were 
synchronized a second time, and diluted to 1% parasitemia the following day.  Assays were initiated 
on day 5 by distributing 3mL of prepared cultures into each well of 6-well plates (Corning Life 
Sciences) at 0.1% ring stage parasitemia, and maintained in sealed chambers (Billups-Rothenberg) 
gassed daily.  Smears from each well (technical replicates) were made every 48h (18 per cycle for 
each parasite clone).  Parasitemia was determined and the fold change for each life cycle was 
calculated.  By the 4th cycle, cultures were nearing or reaching their crash level as described by 
Fairhurst et al. (Fairhurst et al., 2003).  Five independent biological replications (n = 5) were 
generated for each clone.  Differences were assessed using an unpaired student t-test in all growth 
studies. 
 
2.3. [3H] Hypoxanthine-incorporation growth assay 
Parasites were synchronized twice approximately 44h apart as described above.  One cell cycle 
(approximately 48h) after the second synchronization, 175µL of parasite cultures were distributed 
into flat-bottom 96-well plates (Corning Life Sciences) at 1.0% parasitemia and 1.0% hematocrit in 
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low Hx CM (2.94µM).  Twelve wells contained RBC controls (no parasites).  Dd2 and HB3 were 
distributed evenly among the remaining wells to eliminate plate-to-plate bias in the comparisons.  
Duplicate plates were prepared for each experimental series. Plates were incubated in sealed, gassed 
chambers for 48h.  After 48h, 75µL were removed from each well and 100µL of 0.76µCi/mL of 
[3H] Hx-monohydrochloride (Perkin Elmer) in CM were added.  Duplicate plates were removed 
after 12h or 24h, wrapped in parafilm and frozen at -80ºC to lyse cells. Thawed, lysed cells were 
transferred onto glass fiber printed filtermats (Wallac) using a cell harvester (Tomtec), mats were 
dried, and placed in bags (Perkin Elmer) containing 3.5mL of Betaplate Scint fluid (Perkin Elmer), 
sealed and read on a scintillation counter (1450 Micro beta, Perkin Elmer).  Growth values were 
calculated from counts per minute (CPM) at 12h and 24h. Six to 9 independent biological 
replications were conducted.  The 12h time point captures the parasites in a relatively metabolically 
inactive early ring stage.  The 24h time point captures the late rings transitioning to early 
trophozoites during which the parasites are highly metabolically active (Yayon et al., 1983).   
 
2.4. Cycle time 
Cultures were tightly synchronized by sorbitol on consecutive days and resuspended in 5mL at 1% 
parasitemia.  Experiments were initiated with schizonts stages following the second 
synchronization.  Segmenting schizonts provide a visually definitive, narrow morphological 
window (approximately 4h) for precise stage identification.  Progression of parasite throughout the 
erythrocytic cycle was monitored using Giemsa-stained smears, and the time between segmenter 
peaks in sequential cycles.  A small volume smear (approximately 50 µl) from each culture was 
made every 2h, originating from the same culture for each biological replicate, throughout the 12h 
window spanning the schizont peak for four consecutive life cycles.  Cycle time is defined as the 
duration between the peak schizont parasitemias.  This series was conducted independently for three 
biological replicates with three technical replications of each biological replication (for statistical 
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analyses, n = biological replicates).   Additionally, to ascertain stage divergences throughout the 
entire cell cycle, we conducted an independent series of smears at 1h intervals spanning 50h for 
each clone. Time zero was defined as one hour after final synchronization at peak rings.  Percent of 
rings, trophozoites, and schizonts was calculated from each smear.  A lowess curve was fitted to the 
50 data points using GraphPad Prism software.   
 
2.5. Determining number of merozoites per schizont 
Cultures were grown to 20mL at 6-8% parasitemia of predominantly late-stage parasites.  Mature 
schizonts were purified by passage through a VarioMACS separation magnetic column (Miltenyi 
Biotec) to obtain highly concentrated late-stage parasites following manufacturer’s guidelines 
(approximately 90% parasitemia consisting entirely schizonts) (Balu, 2005).  The schizont pellet 
was resuspended in 200µL of CM and a smear was made and stained with Giemsa.  The number of 
merozoites per schizont was counted using light microscopy (1000X).  Only mature schizonts 
(segmenters) were counted as they have undergone complete schizogony and reflect the final 
number of new merozoites produced.  Schizonts were deemed mature when the parasite vacuolar 
membrane was indistinguishable from the RBC membrane, contained a single pigmented digestive 
vacuole, and had clearly separated merozoites with limited overlaps.   Fifty to sixty schizonts were 
counted for each of five independently replicated experiments per clone.  The mean, median, mode 
and range of merozoites per schizont were calculated.   
 
2.6. Merozoite invasion  
The schizont pellet from the magnetic synchronization described above was used to initiate invasion 
assays.  A volume of 6.95µL of the schizont pellet was added to 43.05µL of RPMI to yield 1.0% 
parasitemia.  Two-fold dilutions were made from this stock to give starting parasitemias of 0.5%, 
0.25%, and 0.125%.  Fresh uninfected 5mL RBC cultures in 6-well plates were inoculated with 
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20µL of volume from each of the dilutions.  Cultures were incubated for 12h to allow invasion of 
RBC.  Smears were made and the number of RBC infected with new rings was counted per 2000 
RBC.  This was repeated for three independent experiments. To account for the effect of varying 
numbers of merozoites in the schizonts used to initiate the invasion assay, invasion efficiency was 
calculated using the equation:  
startaveraqge
new
aparasitemimerozoite
aparasitemi
Efficiency
%*
%
=      (Equation 1) 
 
3. Results  
3.1. Visual counts: Dd2 proliferates faster than HB3 over complete cycles  
Giemsa-stained blood smear parasitemias demonstrate the quantitative differences in complete 
cycle proliferation rates between Dd2 and HB3 (Fig. 1A); Dd2 outgrows HB3 as indicated by fold 
change.  Both parasites exhibit an approximate 6-fold change in the first cycle, initiated at 0.1% 
rings; however the difference between clones is small.  The most pronounced difference is observed 
in the second cycle during which Dd2 and HB3 expanded by 6.84-fold and 3.03-fold, respectively 
(P < 0.01) (Fig. 1B, left y-axis, Table 1).  As parasitemia increased in later stages, there was little 
difference in per cycle fold change, likely reflecting resource limitations and deteriorating medium 
quality.  Although strain-specific growth at high parasite densities was not the focus of these 
studies, both cultures exhibited signs of stress at high parasitemia similar to those observed by 
Fairhurst et al.(Fairhurst et al., 2003) and Dd2 began to crash at day 6 (end of cycle 3).  To 
determine if the starting parasitemia was a factor in parasite fold change, a growth assay was set up 
with starting parasitemias of 0.125%, 0.25% and 1.0%.  As previously observed, no significant 
differences were observed between Dd2 and HB3 in fold change for the first cycle at any of the 
three starting parasitemias.  However, cycle 2 exhibits significant fold changes differences between 
parasite lines at starting parasitemias 0.125% and 0.25%, but not 1.0%.   
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3.2. [3H] Hypoxanthine-incorporation accurately reports difference in proliferation   
Hx-incorporation in the first 12h following a full cycle accurately reports growth differences as 
measured with visual counts (Fig. 1B).  Dd2 incorporates significantly more Hx than HB3 at both 
12h and 24h (P < 0.0001); however, at 24h of Hx incorporation, a much higher growth differential 
(4.3X) is observed between the two clones.  Hx-incorporation reporting of growth is stage 
dependent as a reflection of nucleic acid production associated with both transcription and DNA 
replication, a window of approximately 4-8h (Chulay et al., 1983; Yayon et al., 1983).  A 
divergence in the cycle time of the parasite may result in missing the optimal window of 
incorporation and therefore explains some of the variation in the data at the 24h incorporation time 
point.  This observation suggests that Dd2 has begun DNA replication earlier than HB3 indicating a 
subtle divergence in cycle time.  
 
3.3. Dd2 erythrocytic cycle is shorter than HB3 due to a shorter ring stage 
Highly synchronous parasite cultures were monitored to determine the duration between the peak 
prevalence of mature schizonts.  Both clones diverge from the presumed 48h P. falciparum cycle.  
HB3 parasites transition through the complete cycle at an interval of approximately 50h; Dd2 
undergoes a significantly faster RBC cycle (44h, P = 0.0012) (Fig. 2A, Table 2).  Slight changes in 
temperature resulting from sample collection may have an effect on progression of the parasite 
through its erythrocytic cycle.  However, these aberrations would affect both parasite lines equally 
and therefore should not have a bearing on the difference observed between parasites.  These 
differences are robust as the cycle length in each line is stable over several cycles and in biological 
replicates.  In addition, Dd2 does not retain synchrony to the degree of HB3, which attains nearly 
90% rings over each of 3 consecutive cycles.  To further elaborate the divergence in the cell cycle 
between these clones, an additional experiment was conducted at 1h resolution over the complete 
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cycle to highlight the successive increases and decreases of each stage and to identify the point of 
divergence (Fig. 2B).  The shorted cycle of Dd2 is due to a more rapid transition from rings to 
trophozoites.   
 
3.4. Dd2 generates more merozoites per schizont than HB3 
Mature schizonts of Dd2 and HB3 contain, on average, 18 and 16 merozoites, respectively (Fig. 3). 
Only mature segmenting schizonts were counted to ensure that schizogony was completed.  These 
subtle differences were stable over 8-10 biological replicates.  For each replicate Dd2 generated 
schizonts containing between 8-24 merozoites, while HB3 produced 8-20 (Table 3); Dd2 always 
produced a higher maximum than HB3.  Comparisons of synchronized and unsynchronized cultures 
generated the same distributions (data not shown) demonstrating that if only segmenters are 
counted, merozoite number is stable and not a reflection of schizont maturity or culture conditions.  
This confirms segmenters have completed schizogony.  A large majority (85-90%) of merozoites 
counted for both clones were even numbers.  To confirm these observations, slides were blinded 
and recounted by 3 different individuals.  Of 140 schizonts meeting the criteria for counting, only 9 
(6.4%) contained odd numbers of merozoites.  These results suggest that the rare odd-numbered 
counts may reflect counting errors due to overlapping nuclei not discernable by light microscopy.  
Likewise, the confirmed preponderance of even numbers indicates that counts were accurate. 
 
3.5. Dd2 merozoites invade new RBC at a higher rate than HB3  
Dd2 consistently reinvades at a rate nearly 3X greater than HB3 (Fig. 4A, B).  This difference does 
not change if multiple parasites in a single RBC are counted as a single invasion event or if each 
new ring is counted separately, indicating that that rate of multiple invasions of a single RBC does 
not vary between these clones.  We observe a decrease in the number of multiply invaded RBCs 
when cultures are shaken; however, the difference in invasion remains consistent between parasite 
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lines (data not shown).  Because Dd2 produces more merozoites per schizont than HB3, an invasion 
efficiency rate was calculated using Equation 1.  The maximum invasion efficiency of Dd2 per 
single schizont is about 35% compared to 25% for HB3 (Fig. 4B).  Invasion is impacted by parasite 
density (starting parasitemia), but no difference is observed between parasites lines. 
 
4. Discussion 
Strain-specific proliferation rates can highlight components of differential virulence and fitness of 
malaria parasites. Dd2 and HB3 originate from isolates from Indochina and Honduras, respectively. 
More importantly, these clones represent vastly different drug selection histories: Dd2 is a fast-
growing, MDR parasite from a region where MDR is widespread, while HB3 is a generally drug 
sensitive, wild type line. Important questions about the maintenance and spread of drug resistant 
malaria include possible relationships between drug selection and growth rates. One tool to address 
such questions is quantitative trait loci (QTL) mapping using the segregating progeny population of 
a cross between HB3 and Dd2 to generate a list of candidate genes that could contribute to parasite 
growth.  However, to maximize the power of QTL mapping and other genomic approaches, it is 
first essential to understand the fine detail of their phenotypic differences.   
 
Methods of measuring parasite growth generally rely on a surrogate indicator, typically Hx, 
calibrated to parasitemia as determined by blood smears.  Despite attempts to clarify and control 
extraneous factors in Hx-incorporation, subtle variations in culture parameters lead to extensive 
biological noise.  Consequently, growth assays have evolved to blur this variation by using 
asynchronous cultures and extending assays over complete cycles to minimize the impact of stage-
specificity and within-cycle variation.  These sources of variation are biologically relevant.  For 
example, standard Hx-based assays provide robust inference of proliferation and viability and are 
easily adapted to semi-high-throughput applications, e.g. for drug concentration-effect curves.  
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However, this approach ignores the fine-tuned underlying cell biological and developmental steps 
that influence parasite proliferation.  Stage-specific events, most notably invasion, are especially 
susceptible to misinterpretation using standard bulk Hx assays.  Early efforts systematically 
examined the parameters influencing Hx reporting of parasite proliferation (Chulay et al., 1983; 
Yayon et al., 1983); we build on this approach to score nested traits that contribute to clone-specific 
growth rates: cell cycle duration, merozoite production, and merozoite re-invasion.  The difference 
in proliferation rates between Dd2 and HB3 over complete cycles results from Dd2’s shorter cycle 
time, production of more merozoites per schizogony, and higher invasion rates.  
 
Visual counts and Hx-incorporation confirm our anecdotal observations that Dd2 is a faster-
proliferating parasite (Fig. 1).  Hx-incorporation in the 12h following a complete cycle of growth 
effectively recapitulates the smear-determined growth differences; however, the 24h incorporation 
window reported a much larger growth advantage for Dd2.  Though both methods identify 
differences between Dd2 and HB3, it is not surprising that the Hx-incorporation counts at 24h do 
not match fold change measured with smears because  starting parasitemias were different. This is 
consistent with observations that Hx-incorporation accurately reflects visual counts only in a narrow 
range of parameters (0.4% or less parasitemia after 48h of growth and 18h of incorporation) 
(Chulay et al., 1983).  The majority of Hx-incorporation occurs in the trophozoite stage and reflects 
the rapid increase in DNA replication and transcription (Desjardins et al., 1979; Chulay et al., 1983; 
Yayon et al., 1983; Llinas et al., 2006).  Llinas et al. demonstrate remarkably well conserved strain-
specific P. falciparum transcription profiles only after the data are normalized to account for cycle 
time divergence; specific cycle durations are not reported (Llinas et al., 2006). 
 
P. falciparum is famous for its 48h erythrocytic cycle and associated cyclical fevers (Roberts and 
Janovy, 2000).  Variations in the length of the cell cycle could contribute to biomass accumulation 
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over many asexual cycles.  We find a significant difference in the duration of the asexual cycle of 
HB3 and Dd2 in RBC as measured from peak schizont prevalence (Fig. 2).  Closer examination at 
1h resolution attributes this difference to a decreased ring to trophozoite transition time in Dd2 (Fig. 
2B).  Janse et al. recently knocked out one of two eukaryotic elongation factors (eef1α) in P. 
berghei resulting in a 2h to 4h increase of the overall cycle time (a 10-20% increase) associated 
with the G1 phase.  The S/M phase does not show any additional change in overall cycle time 
indicating the difference in cycle time is occurring in the early part of the cycle (Janse et al., 2003).  
Transitions between stages are finely highly regulated, although mechanisms are not well 
characterized in malaria parasites.  Progression through the yeast cell cycle is controlled by cyclins 
and cyclin dependent kinases (cdks), for which several orthologs have been identified in 
Plasmodium (Doerig et al., 2002); furthermore, microarray analysis pointed to a number of genes 
that may be involved in regulating the P. falciparum cell cycle, including cyclins and kinases 
(Doerig et al., 2002; Le Roch et al., 2003).  The phenotypes described here do not reveal 
mechanisms, but highlight candidate biological process in which regulatory variation can be tested 
using genetic mapping or gene manipulation approaches.   
 
It is generally stated that P. falciparum schizonts produce 8 – 24 merozoites, but few reports have 
determined this number.  In a recent study, Hayward et al. proposed that growth rate differences in 
genetically modified parasites result from a fitness impact of mutations introduced in pfmdr1, 
however they ruled out differential merozoite production as contributing to growth differences in 
these lines (Hayward et al., 2005).  We observe a significant difference in merozoite production 
between HB3 and Dd2 which produce approximately 16 and 18 merozoites per schizont, 
respectively (Fig. 3). For each independent experiment, the Dd2 maximum always exceeds HB3 (24 
vs 20 merozoites).  The number of merozoites produced is consistent with asynchronous DNA 
replication such that each nuclear division is independent of others, i.e. synchronous replication 
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would yield 2, 4, 8, 16, or 32 merozoites. Furthermore, predominantly even numbers of merozoites 
are generated by both clones; 85 - 90% of schizonts contain an even number of merozoites, as 
confirmed by blinded replicate counts. We suggest that the occasional odd-number count is likely 
counting error.  Read et al. reported odd and even nuclear bodies, however their approach relied on 
counting all schizonts with more than two nuclear bodies from slides of unsynchronized cultures.  
They did not impose our strict criterion of counting only fully segmented schizonts indicating 
schizogony had been completed (Read et al., 1993).   
 
Replication of DNA begins in P. falciparum as early as 26h and ends around 37h post-invasion 
(Chulay et al., 1983; Yayon et al., 1983; Arnot and Gull, 1998).  Nuclear divisions occur in a single 
cell (syncytium) and are distinct from partitioning of components of the new individual cells; 
consequently, the final number of merozoites is not necessarily a direct reflection of DNA 
replication, but also includes additional cellular events of merogony.  Merogony, while not well-
studied in P. falciparum, has been carefully examined the apicomplexan parasite, Theileria parva 
(Shaw and Tilney, 1992).  This process begins with the interconnecting of rhoptries, mitochondria, 
nucleus, and outer plasma membrane in an ordered and manner.  Individual merozoites bud from 
the nuclear mass as membranes form around the interconnected organelles, generating a host cell 
with large numbers of free mature merozoites capable of invading RBC.   
 
Dd2 produces more newly infected RBC than HB3 (Fig. 4A) as determined by counting new rings.  
While it is not feasible to conduct high-throughput studies by direct visualization as done here, 
similar parameters could be adapted to a flow cytometric analysis to detect newly invaded cells 
(ring stages) from a starting population of concentrated, late-stage schizonts. When the differences 
in average starting merozoite numbers are accounted for, the Dd2 growth advantage is maintained, 
but at a lower level (Fig. 4B).  Invasion rates are equally sensitive to starting parasitemia in both 
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clones, an observation that is consistent with reports for P. chabaudi chabaudi (Chimanuka et al., 
1997) in which lower starting parasitemia results in greater invasion efficiency.   
 
Indirect assessments of growth using various reporter systems suffer from limitations in their ability 
to decipher sub-phenotypes that drive parasite proliferation.  Hx-incorporation has been the 
workhorse of dose response and invasion assays to date, however this approach has not been 
effectively adapted to infer sub-cycle traits.  The data presented here suggest that quantitative 
dissection of the growth process is necessary to fully understand the effects of drugs or other 
manipulations on parasite lines.  Refinement of these methods for high-throughput applications are 
needed in parallel with the emergence of powerful genomics tools for assessing these mechanistic 
steps of growth.  For example, in screening compound libraries for antimalarial activity, it will be 
useful pinpoint the specific events of the erythrocytic cycle that are inhibited.  In this study, we 
outline subtle but quantifiable strain-specific differences in traits underlying proliferation rate of P. 
falciparum in RBC.  Dd2’s faster growth can be attributed to a decreased  cycle time and increased 
merozoite production and invasion rates.  These differences in growth between Dd2 and HB3, 
parents of a genetic cross, suggest that progeny from this cross will differentially inherit growth 
traits, facilitating QTL analysis to find candidate growth genes.  Our observation that laboratory 
cultured MDR parasites derived from S.E. Asia, including Dd2, tend to incorporate Hx at high rates 
could suggest a link between parasite growth and fitness and virulence.  By further understanding 
the genes and mechanisms controlling growth and the relationship they have with drug response, we 
will be able to further characterize the mechanisms of drug resistance.  
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Legends to Figures 
Fig. 1. Dd2 and HB3 proliferation rates by visual smears and [3H]-hypoxanthine. (A) Determination 
of parasitemia via Giemsa-stained smears was used to monitor parasite proliferation (bulk growth) 
per complete cycle (approx. every 2 days).  Parasitemia is determined from 1000 RBC.  (B) The left 
y-axis denotes fold-change in parasitemia between days 2 and 4 (cycle 2) for Dd2 (hashed bars) and 
HB3 (white bars) derived from the same data presented in figure 1A.  The right y-axis shows counts 
per minute (CPM) of Hx-incorporation in Dd2 and HB3 at 12h and 24h post-labeling (labeling 
occurs after one complete 48h cycle).  The starting parasitemia for fold-change is similar to that 
used for Hx-incorporation.  At 12h the Hx-incorporation method best approximates the parasitemia 
determined by fold change.  All data is based on 5-6 independent replicates.  Error bars represent 
SEM.  Unpaired t-tests indicate significance between parasite lines: **** P<0.0001, *** P<0.001, 
**P<0.01, *P<0.05.  
 
Fig. 2. Cycle time and stage duration comparisons of Dd2 and HB3.  (A) Three biological replicates 
consisting of Giemsa-stained smears counted 1000 RBC every 2h over a 12h peak period for three 
consecutive cycles each.  The average cycle time for Dd2 and HB3 is 44.1h and 49.7h respectively.  
Bars represent three biological replicates.  Error bars are SEM.  An unpaired t-test gives a P<0.005.  
(B) Hourly smears taken throughout the erythrocytic cycle (50h) show a decreased time in the ring 
and trophozoite stages for Dd2 compared to HB3.     
 
Fig. 3. Merozoites generated in Dd2 and HB3 schizonts.  (A) Magnetically purified schizonts are 
viewed by light microscopy to determine the number of merozoites produced per schizont.  Five 
replicates consisting of a minimum of 50 schizonts are counted.  Error bars represent the SEM.  
Unpaired t-tests comparing merozoite number between Dd2 and HB3 give a P<0.05 for 10, 20, and 
22.  (B) Representative images of Dd2 and HB3 countable mature schizonts are shown. 
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Fig. 4. Invasion in Dd2 and HB3.  (A) The number of new rings per 2000 RBC is determined by 
light microscopy.  Fold change differences between Dd2 and HB3 in invasion are determined for all 
replicates at each starting parasitemia giving an average overall fold change of 2.99X.  (B) The 
invasion efficiency of merozoites is calculated using Equation 1.  Data points represent a minimum 
of 3 biological replicates.  Error bars are SEM.  Unpaired t-test gives P<0.05 where indicated by *.   
 
 
